Managing Extramacular Circumscribed Choroidal Hemangioma with Green Laser and Anti-Vascular Endothelial Growth Factor Injection in Times of the Unavailability of Photodynamic Therapy
Circumscribed choroidal hemangioma (CCH), an orange–red, well-circumscribed benign neoplasm of choroidal vasculature. Ancillary tests for diagnosis are fundus fluorescein angiography, indocyanine green angiography, optical coherence tomography (OCT), OCT angiography, and ultrasound or magnetic reson...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
| Series: | Delhi Journal of Ophthalmology |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/DLJO.DLJO_6_23 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Circumscribed choroidal hemangioma (CCH), an orange–red, well-circumscribed benign neoplasm of choroidal vasculature. Ancillary tests for diagnosis are fundus fluorescein angiography, indocyanine green angiography, optical coherence tomography (OCT), OCT angiography, and ultrasound or magnetic resonance imaging. It is usually associated with cystoid macular edema, subretinal fluid (SRF), subretinal fibrosis, or retinoschisis. Choroidal hemangioma needs treatment, when it is associated with visual symptoms and exudative retinal detachment. Photodynamic therapy is the first-line treatment, but currently, there is an unavailability of verteporfin dye. We are reporting an interesting case of a 37-year-old male diagnosed with CCH at our center, who presented with significant visual symptoms due to associated SRF at the macula. He was managed with high-duration low-power green laser photocoagulation and anti-vascular endothelial growth factor injection yielding to the resolution of SRF and an improvement in visual outcome. |
|---|---|
| ISSN: | 0972-0200 2454-2784 |